Pfizer starts late-stage trial of mRNA-based flu vaccine

Pfizer Inc said it had started a late-stage U.S. trial of an influenza vaccine involving 25,000 patients, among the first such studies for a messenger RNA flu shot...

Diabetes, patented TB, HIV drugs enter essential list

Prices of several anti-diabetes drugs, patented antivirals used in the treatment of tuberculosis, HIV and hepatitis C are set to get cheaper with their inclusion in the latest edition of National List of Essential Medicines, 2022...

Lupin gets approval for arthritis drug from Canadian health authority

Drug maker Lupin said its biosimilar product Rymti, indicated for the treatment of arthritis, has received approval from the Canadian health authority. The firm's product is the biosimilar of the reference drug Enbrel...

Piramal Pharma in talks for $225 million offshore loans

Piramal Pharma, the recently spun-off unit of Piramal Enterprises, is set to raise $225 million in offshore loans as the drugmaker looks to improve its financial metrics ahead of its impending listing as an independent company, people familiar with..

Drug regulator's approves phase-3 study of intranasal Covid vaccine in 5-18 age group

Hyderabad-based firm Bharat Biotech has sought permission from the drug regulator to conduct phase-3 study of its intranasal COVID-19 vaccine in the 5 to 18 age group. On September 6, the Drugs Controller General of India (DCGI) had approved...

How will wearable technology impact the pharmaceutical industry

Wearable technology in healthcare is growing rapidly with several advanced features which are expected to offer significant advantages for pharma enterprises

Zydus acquires rights of market MonoFerric injection in India, Nepal from Pharmacosmos A/S of Denmark

Zydus Lifesciences Ltd said it has acquired rights to market MonoFerric (iron isomaltoside) injection, used to treat iron deficiency in adult patients, in India and Nepal from Denmark-based Pharmacosmos A/S...

CIPACA partners with ImpactGuru.com to offer financial services to patients in rural areas

Emergency healthcare provider CIPACA has entered into a collaboration with ImpactGuru.com to help patients living in rural areas avail of financial services for their treatment, the firm said. Chennai Interventional Pulmonology and Critical Care...

Allurion launches its world-leading weight management solution in India

Allurion, a firm dedicated to ending obesity, has launched the Allurion Swallowable Capsule in India - the only medical weight-loss device fully approved by the Central Drugs Standard Control Organisation (CDSCO), the national regulatory authority..

TraceX collaborates with CannSol to offer traceable nutraceuticals

TraceX Technologies has partnered with Liechtenstein-based CannSol. Through this collaboration with TraceX, CannSol will offer traceability of each ingredient at every stage of the production of the product...

© 2025 India Pharma Outlook. All Rights Reserved.